BEKHealth and Devana Solutions have finalized an agreement to integrate their platforms. The two companies, makers of the technology solutions targeting clinical research organizations are confident their combined technology will assist research sites, Sponsors and CROs seeking to align the right study with the right sites with the right patients.
“The combination of a site’s historical performance data with a highly precise feasibility AI solution which can cover >90% of study criteria increases the reliability of site selection exponentially”, said Jason Baumgartner, CEO of BEKHealth. “Historical performance is extremely valuable in predicting performance yet alone can lead to disparities and missed opportunities for customers to uncover new patient populations. With Devana’s IGNITE platform having taken off with the leading research organizations, we see this as a natural extension of our platform.”
“A couple of leaders in the site sector whom Jason and I both respect immensely brought us together initially” said Barry Lake, Devana Solutions CEO & Co-Founder, “and the prospect of combining BEKHealth’s platform with Devana IGNITE’s automation of site startup workflows and capture and analytics of trial performance metrics will be revolutionary for Sponsors and CROs seeking predictability and reliability of trial and site performance.”
With a joint commercialization agreement in place, BEKHealth and Devana Solutions are already collaborating on client and prospect referrals for demonstrations of the systems for clinical trial stakeholders including site organizations, Sponsors and CROs while the engineers have begun the work of integrating the platforms in advance of a projected rollout of the combined solution in Q4.